Exploring the in vivo anti-cancer potential of Neosetophomone B in leukemic cells using a zebrafish xenograft model

Copyright © 2024 Elsevier Inc. All rights reserved..

Neosetophomone B (NSP-B) is a unique meroterpenoid fungal secondary metabolite that has previously demonstrated promising anti-cancer properties against various cancer cell lines in vitro. However, its in vivo anti-cancer potential remaines unexplored. To fill this gap in our knowledge, we tested NSP-B's in vivo anti-cancer activity using a zebrafish model, an organism that has gained significant traction in biomedical research due to its genetic similarities with humans and its transparent nature, allowing real-time tumor growth observation. For our experiments, we employed the K562-injected zebrafish xenograft model. Upon treating these zebrafish with NSP-B, we observed a marked reduction in the size and number of tumor xenografts. Delving deeper, our analyses indicated that NSP-B curtailed tumor growth and proliferation of leukemic grafted xenograft within the zebrafish. These results show that NSP-B possesses potent in vivo anti-cancer properties, making it a potential novel therapeutic agent for addressing hematological malignancies.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:435

Enthalten in:

Experimental cell research - 435(2024), 1 vom: 01. Jan., Seite 113907

Sprache:

Englisch

Beteiligte Personen:

Kuttikrishnan, Shilpa [VerfasserIn]
Hasan, Maram [VerfasserIn]
Prabhu, Kirti S [VerfasserIn]
El-Elimat, Tamam [VerfasserIn]
Oberlies, Nicholas H [VerfasserIn]
Pearce, Cedric J [VerfasserIn]
Alali, Feras Q [VerfasserIn]
Ahmad, Aamir [VerfasserIn]
Pourkarimi, Ehsan [VerfasserIn]
Bhat, Ajaz A [VerfasserIn]
Yalcin, Huseyin C [VerfasserIn]
Uddin, Shahab [VerfasserIn]

Links:

Volltext

Themen:

Cell proliferation
Fungal secondary metabolites
Journal Article
Leukemia
Neosetophomone B
Xenograft model
Zebrafish

Anmerkungen:

Date Completed 29.01.2024

Date Revised 29.01.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.yexcr.2023.113907

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM366748335